PDC*line Pharma Revenue

Biotechnology Research • Liège, Walloon Region, Belgium • 21-50 Employees

PDC*line Pharma revenue & valuation

Annual revenue	$3,200,000
Revenue per employee	$128,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$10,300,000
Total funding	$13,300,000

Key Contacts at PDC*line Pharma

Frederique Cantero

Senior Medical Director

Joel Plumas

Co-Founder & Cso

Company overview

Headquarters	PDC*line Pharma SA, Boulevard Patience et Beaujonc n°3 boîte 6, Liège, Liège 4000, BE
Phone number	+3304843505
Website	pdc-line-pharma.com
NAICS	541714
SIC	873
Keywords	Clinical Development, Therapeutic Vaccines, Cancer Immunotherapy, Plasmacytoid Dendritic Cells, Neoantigens
Founded	2014
Employees	21-50
Socials

PDC*line Pharma Email Formats

PDC*line Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@pdc-line-pharma.com), used 62.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@pdc-line-pharma.com	62.5%
{first initial}.{last name}	j.doe@pdc-line-pharma.com	37.5%

About PDC*line Pharma

PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid Dendritic Cells (PDC*line). Based on a robust preclinical package and a first-in-human phase Ib in melanoma, PDC*line Pharma reported promising Phase I/II results in lung cancer (PDC*lung) in 2024. Preparations are now underway for a randomized Phase II trial in lung cancer, and a Phase Ib trial in colorectal cancer with neoantigens (PDC*neo). The company has raised €61M in equity and non-dilutive funding and signed a €108M licensing deal in Asia with the Korean pharmaceutical company, LG Chem Life Science.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

PDC*line Pharma has 13 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore PDC*line Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-01-06	5	$13,300,000

Funding Insights

$13,300,000

Total funding amount

$13,300,000

Most recent funding amount

Number of funding rounds

PDC*line Pharma Tech Stack

Discover the technologies and tools that power PDC*line Pharma's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Slick

JavaScript libraries

PHP

Programming languages

Font Awesome

Font scripts

OVHcloud

Hosting

core-js

JavaScript libraries

Drupal

CMS

PWA

Miscellaneous

lit-element

JavaScript libraries

ZURB Foundation

UI frameworks

Frequently asked questions

PDC*line Pharma is located in Liège, Walloon Region, BE.

You can reach PDC*line Pharma at +3304843505.

PDC*line Pharma generates an estimated annual revenue of $3,200,000. This revenue figure reflects the company's market position and business performance in its industry.

PDC*line Pharma has an estimated valuation of $10,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

PDC*line Pharma was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

PDC*line Pharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

PDC*line Pharma has raised a total of $13,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at PDC*line Pharma

Frederique Cantero

Senior Medical Director

Joel Plumas

Co-Founder & Cso

4.8

40,000 users